1,804
Views
22
CrossRef citations to date
0
Altmetric
Original research

Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity

, , , , , , , , , , , & show all
Article: e1282589 | Received 06 Dec 2016, Accepted 09 Jan 2017, Published online: 03 Mar 2017

References

  • Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1:391-407; PMID:22096659; http://dx.doi.org/10.1158/2159-8290.cd-11-0209
  • Hanash S.. Integrated global profiling of cancer. Nat Rev Cancer 2004; 4:638-44; PMID:15286743; http://dx.doi.org/10.1038/nrc1414
  • Hubbell JA, Thomas SN, Swartz MA. Materials engineering for immunomodulation. Nature 2009; 462:449-60; PMID:19940915; http://dx.doi.org/10.1038/nature08604
  • Best SR, Peng S, Juang CM, Hung CF, Hannaman D, Saunders JR, Wu TC, Pai SI. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 2009; 27:5450-9; PMID:19622402; http://dx.doi.org/10.1016/j.vaccine.2009.07.005
  • Buchan S, Gronevik E, Mathiesen I, King CA, Stevenson FK, Rice J. Electroporation as a “prime/boost” strategy for naked DNA vaccination against a tumor antigen. J Immunol 2005; 174:6292-8; PMID:15879128; http://dx.doi.org/10.4049/jimmunol.174.10.6292
  • Perez-Lopez A, Behnsen J, Nuccio SP, Raffatellu M. Mucosal immunity to pathogenic intestinal bacteria. Nat Rev Immunol 2016; 16:135-48; PMID:26898110; http://dx.doi.org/10.1038/nri.2015.17
  • Lycke N.. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 2012; 12:592-605; PMID:22828912; http://dx.doi.org/10.1038/nri3251
  • Holmgren J, Svennerholm AM. Vaccines against mucosal infections. Curr Opin Immunol 2012; 24:343-53; PMID:22580196; http://dx.doi.org/10.1016/j.coi.2012.03.014
  • Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11:S45-53; PMID:15812489; http://dx.doi.org/10.1038/nm1213
  • Mitragotri S.. Immunization without needles. Nat Rev Immunol 2005; 5:905-16; PMID:16239901; http://dx.doi.org/10.1038/nri1728
  • Cai X, Chiu YH, Chen ZJ. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell 2014; 54:289-96; PMID:24766893; http://dx.doi.org/10.1016/j.molcel.2014.03.040
  • Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immunol-032712-100008
  • Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, Lee H, Arthur CD, White JM, Kalinke U et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med 2011; 208:1989-2003; PMID:21930769; http://dx.doi.org/10.1084/jem.20101158
  • Koshy ST, Mooney DJ. Biomaterials for enhancing anti-cancer immunity. Curr Opin Biotech 2016; 40:1-8; PMID:26896596; http://dx.doi.org/10.1016/j.copbio.2016.02.001
  • Irvine DJ, Swartz MA, Szeto GL. Engineering synthetic vaccines using cues from natural immunity. Nat Mater 2013; 12:978-90; PMID:24150416; http://dx.doi.org/10.1038/nmat3775
  • Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, Golenbock DT. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. J Exp Med 2003; 198:1043-55; PMID:14517278; http://dx.doi.org/10.1084/jem.20031023
  • Hornung V, Latz E. Intracellular DNA recognition. Nat Rev Immunol 2010; 10:123-30; PMID:20098460; http://dx.doi.org/10.1038/nri2690
  • Herber DL, Cao W, Nefedova Y, Novitskiy SV, Nagaraj S, Tyurin VA, Corzo A, Cho HI, Celis E, Lennox B et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med 2010; 16:880-6; PMID:20622859; http://dx.doi.org/10.1038/nm.2172
  • Dhodapkar MV, Dhodapkar KM, Palucka AK. Interactions of tumor cells with dendritic cells: balancing immunity and tolerance. Cell Death Differ 2008; 15:39-50; PMID:17948027; http://dx.doi.org/10.1038/sj.cdd.4402247
  • Zhang Y, Zhang R, Zhang H, Liu J, Yang Z, Xu P, Cai W, Lu G, Cui M, Schwendener RA et al. Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity. Cell Mol Immunol 2012; 9:489-96; PMID:23064105; http://dx.doi.org/10.1038/cmi.2012.33
  • Zhang H, Tang K, Zhang Y, Ma R, Ma J, Li Y, Luo S, Liang X, Ji T, Gu Z et al. Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling. Cancer Immunol Res 2015; 3:196-205; PMID:25477253; http://dx.doi.org/10.1158/2326-6066.cir-14-0177
  • Zhang H, Huang B. Tumor cell-derived microparticles: a new form of cancer vaccine. Oncoimmunology 2015; 4:e1017704; PMID:26405568; http://dx.doi.org/10.1080/2162402x.2015.1017704
  • Chatterjee D, Chaudhuri K. Vibrio cholerae O395 outer membrane vesicles modulate intestinal epithelial cells in a NOD1 protein-dependent manner and induce dendritic cell-mediated Th2/Th17 cell responses. J Biol Chem 2013; 288:4299-309; PMID:23275338; http://dx.doi.org/10.1074/jbc.M112.408302
  • Motta V, Soares F, Sun T, Philpott DJ. NOD-like receptors: versatile cytosolic sentinels. Physiol Rev 2015; 95:149-78; PMID:25540141; http://dx.doi.org/10.1152/physrev.00009.2014
  • Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006; 6:9-20; PMID:16493424; http://dx.doi.org/10.1038/nri1747
  • Tang K, Zhang Y, Zhang H, Xu P, Liu J, Ma J, Lv M, Li D, Katirai F, Shen GX et al. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat Commun 2012; 3:1282; PMID:23250412; http://dx.doi.org/10.1038/ncomms2282
  • Ma J, Zhang Y, Tang K, Zhang H, Yin X, Li Y, Xu P, Sun Y, Ma R, Ji T et al. Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles. Cell Res 2016; 26:713-27; PMID:27167569; http://dx.doi.org/10.1038/cr.2016.53
  • Ran L, Tan X, Li Y, Zhang H, Ma R, Ji T, Dong W, Tong T, Liu Y, Chen D et al. Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials 2016; 89:56-66; PMID:26950165; http://dx.doi.org/10.1016/j.biomaterials.2016.02.025
  • Li D, Jia H, Zhang H, Lv M, Liu J, Zhang Y, Huang T, Huang B. TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b. Oncoimmunology 2012; 1:687-93; PMID:22934260; http://dx.doi.org/10.4161/onci.19854
  • Ma J, Cai W, Zhang Y, Huang C, Zhang H, Liu J, Tang K, Xu P, Katirai F, Zhang J et al. Innate immune cell-derived microparticles facilitate hepatocarcinoma metastasis by transferring integrin αMβ2 to tumor cells. J Immunol 2013; 191:3453-61; PMID:23956429; http://dx.doi.org/10.4049/jimmunol.1300171
  • Tang K, Liu J, Yang Z, Zhang B, Zhang H, Huang C, Ma J, Shen GX, Ye D, Huang B. Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis. Biochem Bioph Res Co 2010; 400:432-6; PMID:20801099; http://dx.doi.org/10.1016/j.bbrc.2010.08.095
  • Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106:1604-11; PMID:15741221; http://dx.doi.org/10.1182/blood-2004-03-1095
  • Johansson ME, Hansson GC. Microbiology. Keeping bacteria at a distance. Science 2011; 334:182-3; PMID:21998374; http://dx.doi.org/10.1126/science.1213909
  • Johansson ME, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastro Hepa 2013; 10:352-61; PMID:23478383; http://dx.doi.org/10.1038/nrgastro.2013.35
  • Pelaseyed T, Bergstrom JH, Gustafsson JK, Ermund A, Birchenough GM, Schutte A, van der Post S, Svensson F, Rodríguez-Piñeiro AM, Nyström EE et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev 2014; 260:8-20; PMID:24942678; http://dx.doi.org/10.1111/imr.12182
  • Ermund A, Schutte A, Johansson ME, Gustafsson JK, Hansson GC. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches. Am J Physiol-Gastr L 2013; 305:G341-7; PMID:23832518; http://dx.doi.org/10.1152/ajpgi.00046.2013
  • Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol 2012; 5:232-9; PMID:22318493; http://dx.doi.org/10.1038/mi.2012.4
  • Poonam P.. The biology of oral tolerance and issues related to oral vaccine design. Curr Pharm Design 2007; 13:2001-7; PMID:17627533; http://dx.doi.org/10.2174/138161207781039814
  • Goto Y, Ivanov II. Intestinal epithelial cells as mediators of the commensal-host immune crosstalk. Immunol Cell Biol 2013; 91:204-14; PMID:23318659; http://dx.doi.org/10.1038/icb.2012.80
  • Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol Today 2000; 21:123-8; PMID:10689299; http://dx.doi.org/10.1016/S0167-5699(99)01575-3
  • Shakhar G, Lindquist RL, Skokos D, Dudziak D, Huang JH, Nussenzweig MC, Dustin ML. Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat Immunol 2005; 6:707-14; PMID:15924144; http://dx.doi.org/10.1038/ni1210
  • Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449:419-26; PMID:17898760; http://dx.doi.org/10.1038/nature06175
  • Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012; 12:265-77; PMID:22437871; http://dx.doi.org/10.1038/nrc3258
  • Kim D, Kim YG, Seo SU, Kim DJ, Kamada N, Prescott D, Philpott DJ, Rosenstiel P, Inohara N, Núñez G. Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin. Nat Med 2016; 22:524-30; PMID:27064448; http://dx.doi.org/10.1038/nm.4075
  • Yin Y, Qin T, Wang X, Lin J, Yu Q, Yang Q. CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites. Mucosal Immunol 2015; 8:799-814; PMID:25492476; http://dx.doi.org/10.1038/mi.2014.110
  • Holmgren J, Adamsson J, Anjuere F, Clemens J, Czerkinsky C, Eriksson K, Flach CF, George-Chandy A, Harandi AM, Lebens M et al. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett 2005; 97:181-8; PMID:15752556; http://dx.doi.org/10.1016/j.imlet.2004.11.009
  • Gutzeit C, Magri G, Cerutti A. Intestinal IgA production and its role in host-microbe interaction. Immunol Rev 2014; 260:76-85; PMID:24942683; http://dx.doi.org/10.1111/imr.12189
  • Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 2014; 14:141-53; PMID:24566914; http://dx.doi.org/10.1038/nri3608
  • Ferreira VH, Dizzell S, Nazli A, Kafka JK, Mueller K, Nguyen PV, Tremblay MJ, Cochrane A, Kaushic C. Medroxyprogesterone acetate regulates HIV-1 uptake and transcytosis but not replication in primarygenital epithelial cells, resulting in enhanced T-cell infection. J Infect Dis 2015; 211:1745-56; PMID:25538276; http://dx.doi.org/10.1093/infdis/jiu832
  • Skoufias DA, Wilson L. Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes. Biochemistry 1992; 31:738-46; PMID:1731931; http://dx.doi.org/10.1021/bi00118a015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.